Items Tagged ‘cll Venetoclax’

March 22, 2018

Venclexta Significantly Reduces Cancer Progression in Chronic Lymphocytic Leukemia

By

CancerConnect News: Venclexta (venetoclax) plus Rituxan (rituximab) significantly reduces the risk of cancer progression or death at two years, compared with Treanda (bendustamine) plus Rituxan in the treatment of chronic lymphocytic leukemia that has recurred following prior therapies. These results were recently presented at the 59th annual meeting of the American Society of Hematology (ASH). […]

View full entry

Tags: Chronic Lymphocytic Leukemia, cll Venetoclax, Leukemia, News, rituxan, rituximab